Loxo Oncology Profitability Analysis

Based on the key profitability measurements obtained from Loxo Oncology's financial statements, Loxo Oncology may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in April. Profitability indicators assess Loxo Oncology's ability to earn profits and add value for shareholders.
For Loxo Oncology profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Loxo Oncology to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Loxo Oncology utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Loxo Oncology's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Loxo Oncology over time as well as its relative position and ranking within its peers.
  
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest.
Please note, there is a significant difference between Loxo Oncology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Loxo Oncology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Loxo Oncology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Loxo Oncology Revenue vs. Current Asset Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Loxo Oncology's current stock value. Our valuation model uses many indicators to compare Loxo Oncology value to that of its competitors to determine the firm's financial worth.
Loxo Oncology is currently regarded as number one stock in current asset category among related companies. It is considered the number one company in revenue category among related companies totaling about  0.92  of Revenue per Current Asset. The ratio of Current Asset to Revenue for Loxo Oncology is roughly  1.08 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Loxo Oncology by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Loxo Oncology's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Loxo Oncology's earnings, one of the primary drivers of an investment's value.

Loxo Revenue vs. Current Asset

Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.

Loxo Oncology

Current Asset

 = 

Cash

+

Deposits

+

Liquid Assets

 = 
156.64 M
Current Asset is important to company's creditors and private equity firms as they will often be interested in how much that company has in current assets since these assets can be easily liquidated in case the company goes bankrupt. However, it is usually not enough to know if a company is in good shape just based on current asset alone; the amount of current liabilities should always be considered.
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.

Loxo Oncology

Revenue

 = 

Money Received

-

Discounts and Returns

 = 
144.8 M
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.

Loxo Revenue vs Competition

Loxo Oncology is considered the number one company in revenue category among related companies. Market size based on revenue of Biotechnology industry is now estimated at about 426.54 Million. Loxo Oncology totals roughly 144.8 Million in revenue claiming about 34% of stocks in Biotechnology industry.

Loxo Oncology Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Loxo Oncology, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Loxo Oncology will eventually generate negative long term returns. The profitability progress is the general direction of Loxo Oncology's change in net profit over the period of time. It can combine multiple indicators of Loxo Oncology, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Loxo Oncology, Inc., a biopharmaceutical company, develops and sells medicines for patients with genetically defined cancers in the United States. Loxo Oncology, Inc. was founded in 2013 and is headquartered in Stamford, Connecticut. Loxo Oncology operates under Biotechnology classification in USA and is traded on NASDAQ General Markets. It employs 59 people.

Loxo Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Loxo Oncology. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Loxo Oncology position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Loxo Oncology's important profitability drivers and their relationship over time.

Use Loxo Oncology in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Loxo Oncology position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Loxo Oncology will appreciate offsetting losses from the drop in the long position's value.

Loxo Oncology Pair Trading

Loxo Oncology Pair Trading Analysis

The ability to find closely correlated positions to Western Union could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Western Union when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Western Union - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Western Union Co to buy it.
The correlation of Western Union is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Western Union moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Western Union moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Western Union can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Loxo Oncology position

In addition to having Loxo Oncology in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Momentum Thematic Idea Now

Momentum
Momentum Theme
Large corporations operating in software, education, financial and car manufacturing industries. The Momentum theme has 40 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Momentum Theme or any other thematic opportunities.
View All  Next Launch
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest.
You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Other Consideration for investing in Loxo Stock

If you are still planning to invest in Loxo Oncology check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Loxo Oncology's history and understand the potential risks before investing.
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Stocks Directory
Find actively traded stocks across global markets